Prognostic impact of immunophenotypic aberrancies of blasts in lower risk myelodysplastic syndrome.

Corrao, Kristen; Rezwan, Siam; Atallah, Ehab; Michaelis, Laura C; Runaas, Lyndsey; Harrington, Alexandra M; Abedin, Sameem

Corrao, Kristen; Rezwan, Siam; Atallah, Ehab; Michaelis, Laura C; Runaas, Lyndsey; Harrington, Alexandra M; Abedin, Sameem.

Afiliación

Corrao K; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, United States.
Rezwan S; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, United States.
Atallah E; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, United States.
Michaelis LC; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, United States.
Runaas L; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, United States.
Harrington AM; Department of Pathology, Medical College of Wisconsin, Milwaukee, WI, United States.
Abedin S; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, United States.

Leuk Res Rep ; 17: 100329, 2022.

Article en En | MEDLINE | ID: mdl-35651540

Palabras clave

Flow cytometry; Lower-risk; Myelodysplastic syndromes; Transfusion dependence

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Leuk Res Rep Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google